The Latest Cardiac and Vascular News
Data will be available to researchers studying a wide range of disease states BOULDER, Colo., Feb. 02, 2022 (GLOBE NEWSWIRE) — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will begin assaying samples from the Multi-Ethnic Study of Atherosclerosis (MESA) study beginning in the […]
Organization recognizes the most promising and innovative health startups in New York NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to New York’s healthcare ecosystem, has recognized the company on […]
Device enables donor lungs to safely travel unprecedented distance of 4,788 Miles with a total ischemic time of over 13 hours CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies announces a milestone achievement for its Paragonix LUNGguard™ System as the device safely completed a record distance for donor lung transport from Alaska to North Carolina. The longest […]
AliveCor launches KardiaMobile Card, the only personal ECG slim enough to fit in a wallet for instant feedback on heart health anytime, anywhere MOUNTAIN VIEW, Calif., Feb. 1, 2022 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of KardiaMobile Card, the slimmest, most convenient personal […]
Aficamten Reduced LVOT Gradients in Patients on Disopyramide With No Instances of Left Ventricular Ejection Fraction Below 50% Findings Support Inclusion of Patients on Disopyramide in SEQUOIA-HCM SOUTH SAN FRANCISCO, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from Cohort 3 of […]
Bergen County’s first hospital to earn recognition from the American College of Cardiology for Transcatheter Valve ENGLEWOOD, N.J., Feb. 1, 2022 /PRNewswire/ — Englewood Health has been recognized by the American College of Cardiology (ACC) with the Transcatheter Valve Certification. This mark of distinction reflects the accomplishments of the Structural Heart and […]
REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY, Mass., Feb. 1, 2022 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced results from its REDUCE LAP-HF II randomized clinical trial, investigating the safety and efficacy of the […]
Independent study validates the first AI-powered device to screen for heart failure during a standard physical exam OAKLAND, Calif., Feb. 1, 2022 /PRNewswire/ — Eko, a digital health company advancing heart and lung disease detection, announced today that the Imperial College of London, in conjunction with the UK National Health Service (NHS), published a study1 which […]
Clinical Trial to Evaluate the Use of OmnySense Technology to Monitor and Analyze Respiratory Sounds HOLON, Israel and TEL AVIV, Israel, Feb. 01, 2022 /PRNewswire/ — Wolfson Medical Center and OmnySense Ltd. have commenced a clinical trial to evaluate the use of OmnySense technology to monitor and analyze respiratory sounds as recorded at the mouth. OmnySense is an Israeli startup […]
MORRISVILLE, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced today that Tenax Therapeutics appointed Robyn Hunter to its Board of Directors, effective January […]
